XML 12 R1.htm IDEA: XBRL DOCUMENT v3.25.0.1
Document And Entity Information - USD ($)
 12 Months Ended
Dec. 27, 2024
Feb. 18, 2025
Jun. 28, 2024
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 27, 2024    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Entity Registrant Name STAAR SURGICAL CO    
Entity Central Index Key 0000718937    
Current Fiscal Year End Date --12-27    
Entity Filer Category Large Accelerated Filer    
Trading Symbol STAA    
Entity Common Stock, Shares Outstanding   49,325,372  
Entity Emerging Growth Company false    
Entity Small Business false    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Document Financial Statement Error Correction [Flag] false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 2,340,566,448
Entity File Number 0-11634    
Entity Tax Identification Number 95-3797439    
Entity Address, Address Line One 25510 Commercentre Drive    
Entity Address, City or Town Lake Forest    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92630    
City Area Code 626    
Local Phone Number 303-7902    
Entity Interactive Data Current Yes    
Entity Incorporation, State or Country Code DE    
Title of 12(b) Security Common    
Security Exchange Name NASDAQ    
Document Annual Report true    
Document Transition Report false    
Documents Incorporated by Reference

Portions of the registrant’s definitive proxy statement relating to its 2025 annual meeting of stockholders, which will be filed with the Securities and Exchange Commission pursuant to Regulation 14A within 120 days of the close of the registrant’s last fiscal year, are incorporated by reference into Part III of this report.

    
Auditor Name BDO USA, P.C.    
Auditor Location Los Angeles, California    
Auditor Firm ID 243    
Auditor Opinion [Text Block]

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of STAAR Surgical Company (the “Company”) as of December 27, 2024 and December 29, 2023, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the three fiscal years in the period ended December 27, 2024, and the related notes and financial statement schedule listed in the accompanying index (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 27, 2024 and December 29, 2023, and the results of its operations and its cash flows for each of the three fiscal years in the period ended December 27, 2024, in conformity with accounting principles generally accepted in the United States of America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the Company's internal control over financial reporting as of December 27, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and our report dated February 21, 2025 expressed an unqualified opinion thereon.